Article 2 Quality system standards and specifications 1.
Member States shall ensure that the quality system in place in all blood establishments complies with the Community standards and specifications set out in the Annex to this Directive. 2.
Good practice guidelines shall be developed by the Commission, in accordance with Article 28 of Directive 2002/98/EC, for the interpretation of the Community standards and specifications referred to in paragraph 1.
When developing these guidelines, the Commission shall take fully into account the detailed principles and guidelines of good manufacturing practice, as referred to in Article 47 of Directive 2001/83/EC. 3.
Member States shall ensure that for blood and blood components imported from third countries and intended for use or distribution in the Community, there is a quality system for blood establishments in the stages preceding importation equivalent to the quality system provided for in Article 2.
Article 4 Entry into force This Directive shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
Article 5 Addressees This Directive is addressed to the Member States.
Done at Brussels, 30 September 2005.
For the Commission Markos Kyprianou Member of the Commission [1] OJ L 33, 8.2.2003, p. 30. [2] OJ L 203, 21.7.1998, p. 14. [3] OJ L 311, 28.11.2001, p. 67.
Directive as last amended by Directive 2004/27/EC (OJ L 136, 30.4.2004, p. 34). [4] OJ L 262, 14.10.2003, p. 22. [5] OJ L 91, 30.3.2004, p. 25. -------------------------------------------------- ANNEX Quality system standards and specifications 1.
INTRODUCTION AND GENERAL PRINCIPLES 1.1.
Quality system 1.
PERSONNEL AND ORGANISATION 1.
Training programmes shall be in place and shall include good practice. 4.
There shall be written safety and hygiene instructions in place adapted to the activities to be carried out and are in compliance with Council Directive 89/391/EEC [1] and Directive 2000/54/EC of the European Parliament and of the Council [2]. 3.
Storage area 1.
Where relevant, materials, reagents and equipment shall meet the requirements of Council Directive 93/42/EEC [3] for medical devices and Directive 98/79/EC of the European Parliament and of the Council [4] for in vitro diagnostic medical devices or comply with equivalent standards in the case of collection in third countries. 4.
BLOOD COLLECTION, TESTING AND PROCESSING 6.1.
Donor eligibility 1.
They shall take place before each donation and comply with the requirements set out in Annex II and Annex III to Directive 2004/33/EC. 2.
Collection of blood and blood components 1.
The sterile blood bag systems used for the collection of blood and blood components and their processing shall be CE-marked or comply with equivalent standards if the blood and blood components are collected in third countries.
The batch number of the blood bag shall be traceable for each blood component. 3.
Laboratory testing 1.
Each donation shall be tested in conformity with the requirements laid down in Annex IV to Directive 2002/98/EC. 3.
The quality of the laboratory testing shall be regularly assessed by the participation in a formal system of proficiency testing, such as an external quality assurance programme. 6.
Processing and validation 1.
The labelling system for the collected blood, intermediate and finished blood components and samples must unmistakably identify the type of content, and comply with the labelling and traceability requirements referred to in Article 14 of Directive 2002/98/EC and Commission Directive 2005/61/EC [5].
For autologous blood and blood components, the label also shall comply with Article 7 of Directive 2004/33/EC and the additional requirements for autologous donations specified in Annex IV to that Directive. 6.6.
Release of blood and blood components 1.
In the absence of a validated computerised system for status control the label of a unit of blood or blood component shall identify the release status in accordance with 6.5.1. 3.
In the event that the final component fails release due to a confirmed positive infection test result, in conformity with the requirements set out in Section 6.3.2 and 6.3.3, a check shall be made to ensure that other components from the same donation and components prepared from previous donations given by the donor are identified.
There shall be an immediate update of the donor record. 7.
STORAGE AND DISTRIBUTION 1.
The quality system of the blood establishment shall ensure that, for blood and blood components intended for the manufacture of medicinal products, the storage and distribution requirements shall comply with Directive 2003/94/EC. 2.
Autologous blood and blood components as well as blood components collected and prepared for specific purposes shall be stored separately. 4.
Appropriate records of inventory and distribution shall be kept. 5.
Packaging shall maintain the integrity and storage temperature of blood or blood components during distribution and transportation. 6.
Return of blood and blood components into inventory for subsequent reissue shall only be accepted when all quality requirements and procedures laid down by the blood establishment to ensure blood component integrity are fulfilled. 8.
NON-CONFORMANCE 9.1.
Deviations Blood components deviating from required standards set out in Annex V to Directive 2004/33/EC shall be released for transfusion only in exceptional circumstances and with the recorded agreement of the prescribing physician and the blood establishment physician. 9.2.
Corrective and preventive actions 1.
SELF-INSPECTION, AUDITS AND IMPROVEMENTS 1.
All results shall be documented and appropriate corrective and preventive actions shall be taken in a timely and effective manner. [1] OJ L 183, 29.6.1989, p. 1. [2] OJ L 262, 17.10.2000, p. 21. [3] OJ L 169, 12.7.1993, p. 1.
Directive as last amended by Regulation (EC) No 1882/2003 of the European Parliament and of the Council (OJ L 284, 31.10.2003, p. 1). [4] OJ L 331, 7.12.1998, p. 1.
Directive as amended by Regulation (EC) No 1882/2003. [5] See page 32 of this Official Journal. --------------------------------------------------
